Congenital functional phagocyte defect

Congenital functional phagocyte defects are a group of rare inherited primary immunodeficiency disorders in which phagocytic cells (such as neutrophils, monocytes, and macrophages) are present in normal or near-normal numbers but fail to function properly. Phagocytes are a critical component of the innate immune system, responsible for engulfing and destroying bacteria, fungi, and other pathogens. When these cells cannot carry out their protective roles effectively, patients become highly susceptible to severe, recurrent, and often life-threatening infections. This category encompasses several specific conditions affecting different aspects of phagocyte function, including defects in chemotaxis (cell migration toward infection), pathogen recognition, ingestion (phagocytosis), or intracellular killing mechanisms. The immune system is the primary body system affected, but because infections can occur in virtually any organ, patients commonly experience recurrent skin abscesses, pneumonia, lymphadenitis, deep-seated organ abscesses (particularly hepatic and pulmonary), osteomyelitis, and severe fungal infections. Affected individuals may also develop granulomatous inflammation in various tissues. Onset is typically in infancy or early childhood, when the frequency and severity of infections become apparent. Management of congenital functional phagocyte defects focuses on aggressive prevention and treatment of infections using prophylactic antibiotics and antifungal agents. Interferon-gamma therapy is used in some subtypes, particularly chronic granulomatous disease. Hematopoietic stem cell transplantation (HSCT) can be curative for several of these conditions and is considered in severe cases. Gene therapy is under investigation for select subtypes. Supportive care, including prompt treatment of infections and careful monitoring, remains essential for improving quality of life and long-term outcomes.

Common questions about Congenital functional phagocyte defect